Cargando…

Effect of prostaglandin analogues on central corneal thickness in patients with glaucoma: A systematic review and meta-analysis with trial sequential analysis

The objective of this meta-analysis was to evaluate the effect of prostaglandin analogues (PGA) on central corneal thickness (CCT) in patients with glaucoma. Key electronic databases were searched for randomized controlled trials (RCTs) involving the CCT effects of prostaglandin use for glaucoma. Pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadri, Rajani, Shetty, Akansha, Parameshwar, Devika, Kudva, Ajay A, Achar, Asha, Shetty, Jayaram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332944/ https://www.ncbi.nlm.nih.gov/pubmed/35502015 http://dx.doi.org/10.4103/ijo.IJO_1971_21

Ejemplares similares

Mascara Induced Milphosis, an Etiological Evaluation
por: Kadri, Rajani, et al.
Publicado: (2013)

Corneal endothelial cell changes in diabetics versus age group matched nondiabetics after manual small incision cataract surgery
por: Kudva, Ajay A, et al.
Publicado: (2020)

Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
por: Park, Ji-Hye, et al.
Publicado: (2021)

Dietary associations with diabetic retinopathy—A cohort study
por: Kadri, Rajani, et al.
Publicado: (2021)

Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
por: Kocabeyoglu, Sibel, et al.
Publicado: (2015)

Prostaglandin analogues in angle closure glaucoma
por: Gupta, Pulkit, et al.
Publicado: (2011)

Effect of Prostaglandin Analogues on Central Corneal Thickness: 3-Year Follow-up Results
por: Jang, Minsu, et al.
Publicado: (2020)

Effect of Topical Prostaglandin Analogue Therapy on Central Corneal Thickness: A Systematic Review
por: Kim, Jae-Yun, et al.
Publicado: (2022)

Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
por: Zhou, Lin, et al.
Publicado: (2022)

Topical Prostaglandin Analogues and Conjunctival Inflammation in Uveitic Glaucoma
por: Taylor, Simon RJ, et al.
Publicado: (2012)

Trichilemmal Cyst of the Bulbar Conjunctiva: A Rare Presentation
por: Kadri, Rajani, et al.
Publicado: (2013)

Effect of fluidics on corneal endothelial cell density, central corneal thickness, and central macular thickness after phacoemulsification with torsional ultrasound
por: Das, Sudeep, et al.
Publicado: (2015)

Effects of Preservative on the Meibomian Gland in Glaucoma Patients Treated with Prostaglandin Analogues
por: Ha, Jun Young, et al.
Publicado: (2019)

New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
por: Alviset, Gabriel, et al.
Publicado: (2022)

Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
por: Tang, Wenquan, et al.
Publicado: (2019)

Corneal Biomechanical Parameters and Central Corneal Thickness in Glaucoma Patients, Glaucoma Suspects, and a Healthy Population
por: del Buey-Sayas, Mª. Ángeles, et al.
Publicado: (2021)

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
por: Eyawo, Oghenowede, et al.
Publicado: (2009)

Comment on: Evaluation and correlation of corneal endothelium parameters with the severity of primary glaucoma
por: Chaurasiya, Ritesh K, et al.
Publicado: (2023)

Central Corneal Thickness in Iranian Congenital Glaucoma Patients
por: Amini, Heidar, et al.
Publicado: (2012)

Central corneal thickness and corneal endothelial characteristics in healthy, cataract, and glaucoma patients
por: Galgauskas, Saulius, et al.
Publicado: (2012)

The changes of corneal biomechanical properties with long-term treatment of prostaglandin analogue measured by Corvis ST
por: Wu, Na, et al.
Publicado: (2020)

Effects of aqueous suppressants and prostaglandin analogues on early wound healing after glaucoma implant surgery
por: Jung, Kyoung In, et al.
Publicado: (2019)

Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
por: Liu, Yuanzhi, et al.
Publicado: (2019)

Changes in corneal thickness after vitrectomy—Implications for glaucoma practice
por: Gawas, Lisika, et al.
Publicado: (2021)

The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma
por: Meda, Roman, et al.
Publicado: (2017)

Individual and Combined Effects of Diabetes and Glaucoma on Total Macular Thickness and Ganglion Cell Complex Thickness: A Cross-sectional Analysis
por: Shah, Dhruven, et al.
Publicado: (2022)

Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis
por: Diaconita, Vlad, et al.
Publicado: (2018)

Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma
por: Hu, Jason, et al.
Publicado: (2020)

Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
por: Seong, Hyo Jin, et al.
Publicado: (2021)

Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
por: Yoshikawa, Keiji, et al.
Publicado: (2021)

Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients
por: Opazo-Toro, Valeria, et al.
Publicado: (2023)

Central Corneal Thickness in Primary Angle Closure and Open Angle Glaucoma
por: Moghimi, Sasan, et al.
Publicado: (2014)

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials
por: Honrubia, F, et al.
Publicado: (2009)

Influence of a Prostaglandin F2α Analogue on Corneal Hysteresis and Expression of Extracellular Matrix Metalloproteinases 3 and 9
por: Weber, Constance, et al.
Publicado: (2023)

Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
por: Frenkel, Ronald EP, et al.
Publicado: (2007)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
por: Nakano, Tadashi, et al.
Publicado: (2016)

Central corneal thickness in subjects with glaucoma and in normal individuals (with or without pseudoexfoliation syndrome)
por: Kitsos, Georgios, et al.
Publicado: (2009)

Long-term change in central corneal thickness from a glaucoma perspective
por: Choudhari, Nikhil S., et al.
Publicado: (2013)

No differences in central corneal thickness between open-angle and pseudoexfoliation glaucoma patients
por: Ayala, Marcelo, et al.
Publicado: (2017)

Potential for Collider Bias in Studies Examining the Association of Central Corneal Thickness With Glaucoma
por: Khawaja, Anthony P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ij5tfvt7ql0ehis4md547a7bi